OGS and Cystic Fibrosis Foundation Therapeutics enter CF proteomics research collaboration July 24, 2002
Potent and selective NK3 receptor antagonist characterized biochemically and pharmacologically July 23, 2002
Potential antiallergic effects described for chemically modified tetracycline at IUPHAR meeting July 19, 2002
RSS